1.
Li X, He J, Song C. Research Progress on the CDK4/6 Signaling Pathway and Clinical Application of Its Inhibitors in HR+/HER2- Breast Cancer. Health Nexus. 2025;1:31-37. doi:10.63802/healthnexus.V1.2025.148